Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 906

1.

[Effect of salmon calcitonin on postoperative humeral head replacement in elderly patients].

Dai HF, Liu F, Li J, Wang ZH, Lyu YM, Xu C.

Zhongguo Gu Shang. 2019 Feb 25;32(2):136-140. doi: 10.3969/j.issn.1003-0034.2019.02.008. Chinese.

PMID:
30884929
2.

Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.

Liu L, Yang H, Lou Y, Wu JY, Miao J, Lu XY, Gao JQ.

Int J Pharm. 2019 Feb 25;557:170-177. doi: 10.1016/j.ijpharm.2018.12.053. Epub 2018 Dec 28.

PMID:
30597264
3.

Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.

Sladek S, Kearney C, Crean D, Brama PAJ, Tajber L, Fawcett K, Labberte MC, Leggett B, Brayden DJ.

Drug Deliv Transl Res. 2018 Oct;8(5):1421-1435. doi: 10.1007/s13346-018-0557-x.

PMID:
29947020
4.

Treatment of extreme hypercalcaemia: the role of haemodialysis.

Basok AB, Rogachev B, Haviv YS, Vorobiov M.

BMJ Case Rep. 2018 Jun 4;2018. pii: bcr-2017-223772. doi: 10.1136/bcr-2017-223772.

5.

Synergistic and non-synergistic effects of salmon calcitonin and omega - 3 fatty acids on antioxidant, anti-inflammatory, and haematological indices in diabetic rats.

Adeyemi WJ, Olayaki LA.

Biomed Pharmacother. 2018 Mar;99:867-875. doi: 10.1016/j.biopha.2018.01.085. Epub 2018 Feb 20.

PMID:
29710486
6.

In Vitro-In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin.

Hibbins AR, Govender M, Indermun S, Kumar P, du Toit LC, Choonara YE, Pillay V.

J Pharm Sci. 2018 Jun;107(6):1605-1614. doi: 10.1016/j.xphs.2018.02.004. Epub 2018 Feb 13.

PMID:
29452142
7.

Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia.

Sullivan R, Abraham A, Simpson C, Olear E, Carpenter T, Deng Y, Chen C, Insogna KL.

Calcif Tissue Int. 2018 Jun;102(6):666-670. doi: 10.1007/s00223-017-0382-0. Epub 2018 Jan 30.

8.

Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats.

Kilinc E, Dagistan Y, Kukner A, Yilmaz B, Agus S, Soyler G, Tore F.

Clin Exp Pharmacol Physiol. 2018 Jun;45(6):536-546. doi: 10.1111/1440-1681.12915. Epub 2018 Feb 13.

PMID:
29344989
9.

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study.

Lu C, Chen Y, Zhang B, Chen Y, Bai F, Chen D.

Clin Interv Aging. 2017 Oct 12;12:1717-1723. doi: 10.2147/CIA.S140900. eCollection 2017.

10.
11.
12.

Supramolecular nanoparticles of calcitonin and dipeptide for long-term controlled release.

Cao S, Liu Y, Shang H, Li S, Jiang J, Zhu X, Zhang P, Wang X, Li J.

J Control Release. 2017 Jun 28;256:182-192. doi: 10.1016/j.jconrel.2017.04.014. Epub 2017 Apr 13.

PMID:
28414150
13.

Anhydrous reverse micelle nanoparticles: new strategy to overcome sedimentation instability of peptide-containing pressurized metered-dose inhalers.

Huang Z, Wu H, Yang B, Chen L, Huang Y, Quan G, Zhu C, Li X, Pan X, Wu C.

Drug Deliv. 2017 Nov;24(1):527-538. doi: 10.1080/10717544.2016.1269850.

PMID:
28181839
14.

Nasal osteoma and inhaled salmon calcitonin: Coincidence or consequence?

Peña-Rodríguez ZA, Haro-García M, Benito-Navarro JR.

Acta Otorrinolaringol Esp. 2017 Nov - Dec;68(6):366-368. doi: 10.1016/j.otorri.2016.09.004. Epub 2017 Jan 6. English, Spanish. No abstract available.

15.
16.

Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.

Aguirre TAS, Aversa V, Rosa M, Guterres SS, Pohlmann AR, Coulter I, Brayden DJ.

J Control Release. 2016 Sep 28;238:242-252. doi: 10.1016/j.jconrel.2016.07.047. Epub 2016 Jul 30.

PMID:
27480451
17.

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.

Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis BJ, Christiansen C, Karsdal MA; SMC021 investigators.

Bone. 2016 Oct;91:122-9. doi: 10.1016/j.bone.2016.07.019. Epub 2016 Jul 25.

PMID:
27462009
18.

[Postmenopausal osteoporosis treated with acupoint injection of salmon calcitonin:a randomized controlled trial].

Zhou Z, Wang N, Ding C, Zhou X, Zhou J.

Zhongguo Zhen Jiu. 2016 Jul 12;36(7):705-708. doi: 10.13703/j.0255-2930.2016.07.008. Chinese.

PMID:
29231409
19.

The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process.

Poursina N, Vatanara A, Rouini MR, Gilani K, Najafabadi AR.

Acta Pharm. 2016 Jun 1;66(2):207-18. doi: 10.1515/acph-2016-0012.

PMID:
27279064
20.

[Seizure after salmon calcitonin administration: A case report].

Maison O, Pierre S, Charpiat B, Duplessy F, Vial T.

Therapie. 2016 Oct;71(5):529-531. doi: 10.1016/j.therap.2016.03.002. Epub 2016 May 4. French. No abstract available.

PMID:
27262670

Supplemental Content

Loading ...
Support Center